HIGHLIGHTS
- who: . et al. from the Shanghai University of Traditional Chinese Medicine, China have published the research work: A novel transcription factor-based signature to predict prognosis and therapeutic response of hepatocellular carcinoma, in the Journal: (JOURNAL) of 22/07/2022
- what: The authors aimed to systematically investigate the abnormally expressed TFs in HCC and uncover a TF-based signature able to predict prognosis and therapeutic efficacy for patients based on multiple public databases. The study provides potential prognostic biomarkers and corresponding individualized treatment strategies, which aid optimal clinical management and improved clinical outcome for HCC . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.